ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, D. M.
Right arrow Articles by Shennib, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, D. M.
Right arrow Articles by Shennib, H.

The Annals of Thoracic Surgery, Vol 53, 611-616, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Effect of cardiopulmonary bypass on circulating lymphocyte function

DM Nguyen, DS Mulder and H Shennib
Montreal Lung Transplant Program, Quebec, Canada.

Extracorporeal cardiopulmonary bypass (CPB) has been associated with a wide variety of immunological derangements, including a transient postoperative impairment of lymphocyte function. We examined changes in phenotypic and nonspecific cytotoxicity of peripheral blood mononuclear cells after extracorporeal CPB. The peripheral blood samples obtained from 10 patients were subjected to natural killer and cytotoxic T lymphocyte activity assay before and at intervals after CPB. Phenotypic analysis of peripheral blood lymphocytes was performed in 5 patients before and immediately after CPB. We observed a significant increase in peripheral blood CD8+ cells (cytotoxic/suppressor T lymphocytes) (16.1% +/- 2.5% versus 22.5% +/- 2.1%; p less than .005) and a decrease in CD4+ cells (helper/inducer T lymphocytes) (46.1% +/- 3.5% versus 36.1% +/- 3.5%; p less than 0.02) immediately after extracorporeal circulation. The CD8/CD4 ratio in peripheral blood was significantly increased immediately after bypass (0.53 versus 0.80; p less than 0.001). No significant changes in percentages of other leukocyte subsets in peripheral blood were noted. The activity of cytotoxic T lymphocytes and natural killer cells in peripheral blood was impaired on postoperative days 1 and 3 but was restored to preoperative values by removal of mononuclear phagocytes from these cells. The decrease in natural killer cell and cytotoxic T lymphocyte activity in peripheral blood may signify a temporary impairment of the effector arm of the cell-mediated immunity in the post-operative period. The observed changes in peripheral blood phenotype and function may be involved in early organ injury and infectious complications after CPB.


This article has been cited by other articles:


Home page
ICVTSHome page
T. Sano, S. Morita, M. Masuda, Y. Tomita, T. Nishida, H. Tatewaki, and H. Yasui
Cardiopulmonary bypass, steroid administration, and surgical injury synergistically impair memory T cell function and antigen presentation
Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 598 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Masuda, Y. Moriyama, R. Toda, S. Shimokawa, Y. Iguro, S.-i. Watanabe, K. Hisatomi, H. Matsumoto, and A. Taira
The influence of human T lymphotropic virus type I infection on the outcome of cardiovascular surgery
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Katoh, K. Tsuchiya, H. Osawa, W. Sato, G. Matsumura, Y. Iida, S. Suzuki, S. Hosaka, S. Yoshii, and Y. Tada
Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
K. Kawahito, E. Kobayashi, Y. Misawa, H. Adachi, A. Fujimura, T. Ino, and K. Fuse
Recovery From Lymphocytopenia and Prognosis After Adult Extracorporeal Membrane Oxygenation
Arch Surg, February 1, 1998; 133(2): 216 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Hisatomi, A. Kobayashi, Y. Moriyama, S. Shimokawa, H. Toyohira, and A. Taira
COMBINED SUPPRESSIVE EFFECT OF CARDIOPULMONARY BYPASS AND AGING ON CELL-MEDIATED IMMUNITY
J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 140 - 141.
[Full Text]


Home page
PerfusionHome page
P. Hornick
Cardiopulmonary bypass and the adaptive immune system: perspectives on T cell function
Perfusion, May 1, 1996; 11(3): 281 - 290.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.